ZA201908451B - Treatment of sexual dysfunction and improvement in sexual quality of life - Google Patents

Treatment of sexual dysfunction and improvement in sexual quality of life

Info

Publication number
ZA201908451B
ZA201908451B ZA2019/08451A ZA201908451A ZA201908451B ZA 201908451 B ZA201908451 B ZA 201908451B ZA 2019/08451 A ZA2019/08451 A ZA 2019/08451A ZA 201908451 A ZA201908451 A ZA 201908451A ZA 201908451 B ZA201908451 B ZA 201908451B
Authority
ZA
South Africa
Prior art keywords
sexual
improvement
life
treatment
quality
Prior art date
Application number
ZA2019/08451A
Other languages
English (en)
Inventor
M Hare Joshua
Original Assignee
Longeveron Llc
Darcy L Difede
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Longeveron Llc, Darcy L Difede filed Critical Longeveron Llc
Publication of ZA201908451B publication Critical patent/ZA201908451B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
ZA2019/08451A 2017-06-19 2019-12-18 Treatment of sexual dysfunction and improvement in sexual quality of life ZA201908451B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762521765P 2017-06-19 2017-06-19
PCT/US2018/037725 WO2018236680A1 (en) 2017-06-19 2018-06-15 TREATMENT OF SEXUAL DYSFUNCTION AND IMPROVEMENT OF THE QUALITY OF SEXUAL LIFE

Publications (1)

Publication Number Publication Date
ZA201908451B true ZA201908451B (en) 2021-05-26

Family

ID=62952383

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2019/08451A ZA201908451B (en) 2017-06-19 2019-12-18 Treatment of sexual dysfunction and improvement in sexual quality of life

Country Status (12)

Country Link
US (1) US12496316B2 (enExample)
EP (1) EP3641793A1 (enExample)
JP (1) JP7343123B2 (enExample)
KR (1) KR20200017516A (enExample)
CN (1) CN111107858A (enExample)
AU (1) AU2018288653A1 (enExample)
CA (1) CA3067354A1 (enExample)
IL (1) IL271395A (enExample)
SG (1) SG11201912209UA (enExample)
TW (1) TW201919664A (enExample)
WO (1) WO2018236680A1 (enExample)
ZA (1) ZA201908451B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021340971A1 (en) 2020-09-08 2023-03-30 Longeveron, Inc. Treatment of Alzheimer's disease with allogeneic mesenchymal stem cells
EP4376950A1 (en) 2021-07-26 2024-06-05 Longeveron Inc. Use of mesenchymal stem cells in treatment of juvenile hypoplastic left heart syndrome
CA3226181A1 (en) 2021-09-10 2023-03-16 Longeveron Inc. Treatment of aging frailty comprising administering bone marriw derived mesenchymal stem cells
KR102762783B1 (ko) * 2022-01-21 2025-02-05 고현서 심리 프로파일에 따른 행동 습관 제공 방법, 서버, 저장 매체 및 디바이스
WO2025137077A1 (en) 2023-12-19 2025-06-26 Longeveron, Inc. Improved brain architecture and biomarkers in alzheimer's disease with mesenchymal stem cells
WO2025199451A2 (en) 2024-03-21 2025-09-25 Longeveron Inc. Mmp-14 potency assay for mesenchymal stem cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL120266A (en) 1996-02-28 2005-05-17 Pfizer Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions
WO2007149548A2 (en) * 2006-06-22 2007-12-27 Medistem Laboratories, Inc. Treatment of erectile dysfunction by stem cell therapy
WO2010021996A1 (en) * 2008-08-18 2010-02-25 Junta De Beneficiencia De Guayaquil Treatment of injuries to the central nervous system
EP2486930B1 (en) 2009-10-06 2016-03-23 National University Corporation Nagoya University Cell preparation containing adipose tissue derived mesenchymal stem cells for use in the treatment of a condition of no urge to urinate
WO2013173694A2 (en) * 2012-05-18 2013-11-21 The Cooper Health System A method of restoring endothelial/smooth muscle architecture and cell signaling pathways to sexual organs
EA202190962A2 (ru) 2014-05-30 2022-02-28 Оникс Терапьютикс, Инк. Уровни экспрессии иммуноглобулинов в качестве биологического маркера для реакции на ингибитор протеасом
CN105055450A (zh) 2015-02-13 2015-11-18 中国福利会国际和平妇幼保健院 人宫内膜干细胞在制备治疗卵巢早衰的药物中的应用

Also Published As

Publication number Publication date
US12496316B2 (en) 2025-12-16
CN111107858A (zh) 2020-05-05
SG11201912209UA (en) 2020-01-30
AU2018288653A1 (en) 2020-01-16
JP2020524179A (ja) 2020-08-13
TW201919664A (zh) 2019-06-01
WO2018236680A1 (en) 2018-12-27
EP3641793A1 (en) 2020-04-29
JP7343123B2 (ja) 2023-09-12
US20200129558A1 (en) 2020-04-30
CA3067354A1 (en) 2018-12-27
IL271395A (en) 2020-01-30
KR20200017516A (ko) 2020-02-18

Similar Documents

Publication Publication Date Title
ZA201908451B (en) Treatment of sexual dysfunction and improvement in sexual quality of life
IL259474A (en) Device for subcutaneous injection for the treatment of premature ejaculation or erectile dysfunction and the methods of its use
IL274865A (en) Treatment methods with asparaginase
SG11202004680UA (en) Cellular compositions and methods of treatment i
IL283782A (en) Analosomes and methods of use
IL248326B (en) A dimer of buprenorphine and its use in the treatment of diseases of the stomach and intestines
IL268210A (en) Use of gaboxadol in the treatment of tinnitus
IL266518A (en) Methods for the treatment of pulmonary hypertension with combinations of Relinfag and other substances
IL275349A (en) Use of hM4Di in the treatment of seizure disorders
SG11202101235QA (en) Compositions and methods for treating sexual dysfunction and enhancing sexual response and pleasure
GB201511799D0 (en) Composition and methods of treatment
IL273850A (en) Preparations and methods for the treatment of leprosy
GB201614415D0 (en) Enzymes for the treatment of human enterometabolic dysfunction
EP3565541A4 (en) TREATMENT OF SEXUAL DYSFUNCTION
PT3624812T (pt) Métodos e tratamento de trauma
GB201817198D0 (en) Treatment ported sub and method of use
IL271211B1 (en) Acetyl leucine for use in the treatment of migraine
HK40027108A (en) Treatment of sexual dysfunction and improvement in sexual quality of life
PT3408287T (pt) Gdf15 em glaucoma e respetivos métodos de utilização
GB201605127D0 (en) Composition and methods of treatment
IL271727A (en) Method of treatment and their dosage forms
GB201710491D0 (en) Composition and methods of treatment
GB201503371D0 (en) Methods of screening and treatment
IL282686A (en) Treatment and prevention of premature ejaculation
GB201815000D0 (en) Treatment of hypothroidism and related conditions